Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$123.25 - $186.24 $417,201 - $630,422
-3,385 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$126.25 - $231.85 $81,557 - $149,775
646 Added 23.59%
3,385 $577,000
Q4 2021

Feb 14, 2022

BUY
$216.64 - $362.52 $425,697 - $712,351
1,965 Added 253.88%
2,739 $707,000
Q3 2021

Nov 08, 2021

BUY
$205.93 - $447.23 $159,389 - $346,156
774 New
774 $211 Million

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $27.4B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Ipg Investment Advisors LLC Portfolio

Follow Ipg Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ipg Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ipg Investment Advisors LLC with notifications on news.